Copyright Reports & Markets. All rights reserved.

Global Pure EPA Active Pharmaceutical Ingredient (API) Market 2026 by Manufacturers, Regions, Type and Application, Forecast to 2032

Request for Sample of this report
Buy now

1 Market Overview

  • 1.1 Product Overview and Scope
  • 1.2 Market Estimation Caveats and Base Year
  • 1.3 Market Analysis by Type
    • 1.3.1 Overview: Global Pure EPA Active Pharmaceutical Ingredient (API) Consumption Value by Type: 2021 Versus 2025 Versus 2032
    • 1.3.2 Purity 96.5%
    • 1.3.3 Purity 99%
  • 1.4 Market Analysis by Application
    • 1.4.1 Overview: Global Pure EPA Active Pharmaceutical Ingredient (API) Consumption Value by Application: 2021 Versus 2025 Versus 2032
    • 1.4.2 Hypolipidemic Drugs
    • 1.4.3 Cardiovascular Disease Drugs
  • 1.5 Global Pure EPA Active Pharmaceutical Ingredient (API) Market Size & Forecast
    • 1.5.1 Global Pure EPA Active Pharmaceutical Ingredient (API) Consumption Value (2021 & 2025 & 2032)
    • 1.5.2 Global Pure EPA Active Pharmaceutical Ingredient (API) Sales Quantity (2021-2032)
    • 1.5.3 Global Pure EPA Active Pharmaceutical Ingredient (API) Average Price (2021-2032)

2 Manufacturers Profiles

  • 2.1 KD Pharma
    • 2.1.1 KD Pharma Details
    • 2.1.2 KD Pharma Major Business
    • 2.1.3 KD Pharma Pure EPA Active Pharmaceutical Ingredient (API) Product and Services
    • 2.1.4 KD Pharma Pure EPA Active Pharmaceutical Ingredient (API) Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.1.5 KD Pharma Recent Developments/Updates
  • 2.2 Nippon Suisan Kaisha
    • 2.2.1 Nippon Suisan Kaisha Details
    • 2.2.2 Nippon Suisan Kaisha Major Business
    • 2.2.3 Nippon Suisan Kaisha Pure EPA Active Pharmaceutical Ingredient (API) Product and Services
    • 2.2.4 Nippon Suisan Kaisha Pure EPA Active Pharmaceutical Ingredient (API) Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.2.5 Nippon Suisan Kaisha Recent Developments/Updates
  • 2.3 Bizen Chemical
    • 2.3.1 Bizen Chemical Details
    • 2.3.2 Bizen Chemical Major Business
    • 2.3.3 Bizen Chemical Pure EPA Active Pharmaceutical Ingredient (API) Product and Services
    • 2.3.4 Bizen Chemical Pure EPA Active Pharmaceutical Ingredient (API) Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.3.5 Bizen Chemical Recent Developments/Updates
  • 2.4 AK Biopharm
    • 2.4.1 AK Biopharm Details
    • 2.4.2 AK Biopharm Major Business
    • 2.4.3 AK Biopharm Pure EPA Active Pharmaceutical Ingredient (API) Product and Services
    • 2.4.4 AK Biopharm Pure EPA Active Pharmaceutical Ingredient (API) Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.4.5 AK Biopharm Recent Developments/Updates
  • 2.5 Maruha Nichiro
    • 2.5.1 Maruha Nichiro Details
    • 2.5.2 Maruha Nichiro Major Business
    • 2.5.3 Maruha Nichiro Pure EPA Active Pharmaceutical Ingredient (API) Product and Services
    • 2.5.4 Maruha Nichiro Pure EPA Active Pharmaceutical Ingredient (API) Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.5.5 Maruha Nichiro Recent Developments/Updates
  • 2.6 Croda Pharma
    • 2.6.1 Croda Pharma Details
    • 2.6.2 Croda Pharma Major Business
    • 2.6.3 Croda Pharma Pure EPA Active Pharmaceutical Ingredient (API) Product and Services
    • 2.6.4 Croda Pharma Pure EPA Active Pharmaceutical Ingredient (API) Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.6.5 Croda Pharma Recent Developments/Updates

3 Competitive Environment: Pure EPA Active Pharmaceutical Ingredient (API) by Manufacturer

  • 3.1 Global Pure EPA Active Pharmaceutical Ingredient (API) Sales Quantity by Manufacturer (2021-2026)
  • 3.2 Global Pure EPA Active Pharmaceutical Ingredient (API) Revenue by Manufacturer (2021-2026)
  • 3.3 Global Pure EPA Active Pharmaceutical Ingredient (API) Average Price by Manufacturer (2021-2026)
  • 3.4 Market Share Analysis (2025)
    • 3.4.1 Producer Shipments of Pure EPA Active Pharmaceutical Ingredient (API) by Manufacturer Revenue ($MM) and Market Share (%): 2025
    • 3.4.2 Top 3 Pure EPA Active Pharmaceutical Ingredient (API) Manufacturer Market Share in 2025
    • 3.4.3 Top 6 Pure EPA Active Pharmaceutical Ingredient (API) Manufacturer Market Share in 2025
  • 3.5 Pure EPA Active Pharmaceutical Ingredient (API) Market: Overall Company Footprint Analysis
    • 3.5.1 Pure EPA Active Pharmaceutical Ingredient (API) Market: Region Footprint
    • 3.5.2 Pure EPA Active Pharmaceutical Ingredient (API) Market: Company Product Type Footprint
    • 3.5.3 Pure EPA Active Pharmaceutical Ingredient (API) Market: Company Product Application Footprint
  • 3.6 New Market Entrants and Barriers to Market Entry
  • 3.7 Mergers, Acquisition, Agreements, and Collaborations

4 Consumption Analysis by Region

  • 4.1 Global Pure EPA Active Pharmaceutical Ingredient (API) Market Size by Region
    • 4.1.1 Global Pure EPA Active Pharmaceutical Ingredient (API) Sales Quantity by Region (2021-2032)
    • 4.1.2 Global Pure EPA Active Pharmaceutical Ingredient (API) Consumption Value by Region (2021-2032)
    • 4.1.3 Global Pure EPA Active Pharmaceutical Ingredient (API) Average Price by Region (2021-2032)
  • 4.2 North America Pure EPA Active Pharmaceutical Ingredient (API) Consumption Value (2021-2032)
  • 4.3 Europe Pure EPA Active Pharmaceutical Ingredient (API) Consumption Value (2021-2032)
  • 4.4 Asia-Pacific Pure EPA Active Pharmaceutical Ingredient (API) Consumption Value (2021-2032)
  • 4.5 South America Pure EPA Active Pharmaceutical Ingredient (API) Consumption Value (2021-2032)
  • 4.6 Middle East & Africa Pure EPA Active Pharmaceutical Ingredient (API) Consumption Value (2021-2032)

5 Market Segment by Type

  • 5.1 Global Pure EPA Active Pharmaceutical Ingredient (API) Sales Quantity by Type (2021-2032)
  • 5.2 Global Pure EPA Active Pharmaceutical Ingredient (API) Consumption Value by Type (2021-2032)
  • 5.3 Global Pure EPA Active Pharmaceutical Ingredient (API) Average Price by Type (2021-2032)

6 Market Segment by Application

  • 6.1 Global Pure EPA Active Pharmaceutical Ingredient (API) Sales Quantity by Application (2021-2032)
  • 6.2 Global Pure EPA Active Pharmaceutical Ingredient (API) Consumption Value by Application (2021-2032)
  • 6.3 Global Pure EPA Active Pharmaceutical Ingredient (API) Average Price by Application (2021-2032)

7 North America

  • 7.1 North America Pure EPA Active Pharmaceutical Ingredient (API) Sales Quantity by Type (2021-2032)
  • 7.2 North America Pure EPA Active Pharmaceutical Ingredient (API) Sales Quantity by Application (2021-2032)
  • 7.3 North America Pure EPA Active Pharmaceutical Ingredient (API) Market Size by Country
    • 7.3.1 North America Pure EPA Active Pharmaceutical Ingredient (API) Sales Quantity by Country (2021-2032)
    • 7.3.2 North America Pure EPA Active Pharmaceutical Ingredient (API) Consumption Value by Country (2021-2032)
    • 7.3.3 United States Market Size and Forecast (2021-2032)
    • 7.3.4 Canada Market Size and Forecast (2021-2032)
    • 7.3.5 Mexico Market Size and Forecast (2021-2032)

8 Europe

  • 8.1 Europe Pure EPA Active Pharmaceutical Ingredient (API) Sales Quantity by Type (2021-2032)
  • 8.2 Europe Pure EPA Active Pharmaceutical Ingredient (API) Sales Quantity by Application (2021-2032)
  • 8.3 Europe Pure EPA Active Pharmaceutical Ingredient (API) Market Size by Country
    • 8.3.1 Europe Pure EPA Active Pharmaceutical Ingredient (API) Sales Quantity by Country (2021-2032)
    • 8.3.2 Europe Pure EPA Active Pharmaceutical Ingredient (API) Consumption Value by Country (2021-2032)
    • 8.3.3 Germany Market Size and Forecast (2021-2032)
    • 8.3.4 France Market Size and Forecast (2021-2032)
    • 8.3.5 United Kingdom Market Size and Forecast (2021-2032)
    • 8.3.6 Russia Market Size and Forecast (2021-2032)
    • 8.3.7 Italy Market Size and Forecast (2021-2032)

9 Asia-Pacific

  • 9.1 Asia-Pacific Pure EPA Active Pharmaceutical Ingredient (API) Sales Quantity by Type (2021-2032)
  • 9.2 Asia-Pacific Pure EPA Active Pharmaceutical Ingredient (API) Sales Quantity by Application (2021-2032)
  • 9.3 Asia-Pacific Pure EPA Active Pharmaceutical Ingredient (API) Market Size by Region
    • 9.3.1 Asia-Pacific Pure EPA Active Pharmaceutical Ingredient (API) Sales Quantity by Region (2021-2032)
    • 9.3.2 Asia-Pacific Pure EPA Active Pharmaceutical Ingredient (API) Consumption Value by Region (2021-2032)
    • 9.3.3 China Market Size and Forecast (2021-2032)
    • 9.3.4 Japan Market Size and Forecast (2021-2032)
    • 9.3.5 South Korea Market Size and Forecast (2021-2032)
    • 9.3.6 India Market Size and Forecast (2021-2032)
    • 9.3.7 Southeast Asia Market Size and Forecast (2021-2032)
    • 9.3.8 Australia Market Size and Forecast (2021-2032)

10 South America

  • 10.1 South America Pure EPA Active Pharmaceutical Ingredient (API) Sales Quantity by Type (2021-2032)
  • 10.2 South America Pure EPA Active Pharmaceutical Ingredient (API) Sales Quantity by Application (2021-2032)
  • 10.3 South America Pure EPA Active Pharmaceutical Ingredient (API) Market Size by Country
    • 10.3.1 South America Pure EPA Active Pharmaceutical Ingredient (API) Sales Quantity by Country (2021-2032)
    • 10.3.2 South America Pure EPA Active Pharmaceutical Ingredient (API) Consumption Value by Country (2021-2032)
    • 10.3.3 Brazil Market Size and Forecast (2021-2032)
    • 10.3.4 Argentina Market Size and Forecast (2021-2032)

11 Middle East & Africa

  • 11.1 Middle East & Africa Pure EPA Active Pharmaceutical Ingredient (API) Sales Quantity by Type (2021-2032)
  • 11.2 Middle East & Africa Pure EPA Active Pharmaceutical Ingredient (API) Sales Quantity by Application (2021-2032)
  • 11.3 Middle East & Africa Pure EPA Active Pharmaceutical Ingredient (API) Market Size by Country
    • 11.3.1 Middle East & Africa Pure EPA Active Pharmaceutical Ingredient (API) Sales Quantity by Country (2021-2032)
    • 11.3.2 Middle East & Africa Pure EPA Active Pharmaceutical Ingredient (API) Consumption Value by Country (2021-2032)
    • 11.3.3 Turkey Market Size and Forecast (2021-2032)
    • 11.3.4 Egypt Market Size and Forecast (2021-2032)
    • 11.3.5 Saudi Arabia Market Size and Forecast (2021-2032)
    • 11.3.6 South Africa Market Size and Forecast (2021-2032)

12 Market Dynamics

  • 12.1 Pure EPA Active Pharmaceutical Ingredient (API) Market Drivers
  • 12.2 Pure EPA Active Pharmaceutical Ingredient (API) Market Restraints
  • 12.3 Pure EPA Active Pharmaceutical Ingredient (API) Trends Analysis
  • 12.4 Porters Five Forces Analysis
    • 12.4.1 Threat of New Entrants
    • 12.4.2 Bargaining Power of Suppliers
    • 12.4.3 Bargaining Power of Buyers
    • 12.4.4 Threat of Substitutes
    • 12.4.5 Competitive Rivalry

13 Raw Material and Industry Chain

  • 13.1 Raw Material of Pure EPA Active Pharmaceutical Ingredient (API) and Key Manufacturers
  • 13.2 Manufacturing Costs Percentage of Pure EPA Active Pharmaceutical Ingredient (API)
  • 13.3 Pure EPA Active Pharmaceutical Ingredient (API) Production Process
  • 13.4 Industry Value Chain Analysis

14 Shipments by Distribution Channel

  • 14.1 Sales Channel
    • 14.1.1 Direct to End-User
    • 14.1.2 Distributors
  • 14.2 Pure EPA Active Pharmaceutical Ingredient (API) Typical Distributors
  • 14.3 Pure EPA Active Pharmaceutical Ingredient (API) Typical Customers

15 Research Findings and Conclusion

    16 Appendix

    • 16.1 Methodology
    • 16.2 Research Process and Data Source

    According to our (Global Info Research) latest study, the global Pure EPA Active Pharmaceutical Ingredient (API) market size was valued at US$ 367 million in 2025 and is forecast to a readjusted size of US$ 740 million by 2032 with a CAGR of 10.6% during review period.
    Eicosapentaenoic acid (EPA; also icosapentaenoic acid) is an omega-3 fatty acid. It is obtained in the human diet by eating oily fish or fish oil, e.g. cod liver, herring, mackerel, salmon, menhaden and sardine, and various types of edible algae. EPA is used as a prescription medicine to reduce triglyceride levels.
    This report studies Pure EPA (96.5% purity or higher).
    This report is a detailed and comprehensive analysis for global Pure EPA Active Pharmaceutical Ingredient (API) market. Both quantitative and qualitative analyses are presented by manufacturers, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2025, are provided.
    Key Features:
    Global Pure EPA Active Pharmaceutical Ingredient (API) market size and forecasts, in consumption value ($ Million), sales quantity (Tons), and average selling prices (US$/Kg), 2021-2032
    Global Pure EPA Active Pharmaceutical Ingredient (API) market size and forecasts by region and country, in consumption value ($ Million), sales quantity (Tons), and average selling prices (US$/Kg), 2021-2032
    Global Pure EPA Active Pharmaceutical Ingredient (API) market size and forecasts, by Type and by Application, in consumption value ($ Million), sales quantity (Tons), and average selling prices (US$/Kg), 2021-2032
    Global Pure EPA Active Pharmaceutical Ingredient (API) market shares of main players, shipments in revenue ($ Million), sales quantity (Tons), and ASP (US$/Kg), 2021-2026
    The Primary Objectives in This Report Are:
    To determine the size of the total market opportunity of global and key countries
    To assess the growth potential for Pure EPA Active Pharmaceutical Ingredient (API)
    To forecast future growth in each product and end-use market
    To assess competitive factors affecting the marketplace
    This report profiles key players in the global Pure EPA Active Pharmaceutical Ingredient (API) market based on the following parameters - company overview, sales quantity, revenue, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include KD Pharma, Nippon Suisan Kaisha, Bizen Chemical, AK Biopharm, Maruha Nichiro, Croda Pharma, etc.
    This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.
    Market Segmentation
    Pure EPA Active Pharmaceutical Ingredient (API) market is split by Type and by Application. For the period 2021-2032, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
    Market segment by Type
    Purity 96.5%
    Purity 99%
    Market segment by Application
    Hypolipidemic Drugs
    Cardiovascular Disease Drugs
    Major players covered
    KD Pharma
    Nippon Suisan Kaisha
    Bizen Chemical
    AK Biopharm
    Maruha Nichiro
    Croda Pharma
    Market segment by region, regional analysis covers
    North America (United States, Canada, and Mexico)
    Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
    Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
    South America (Brazil, Argentina, Colombia, and Rest of South America)
    Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
    The content of the study subjects, includes a total of 15 chapters:
    Chapter 1, to describe Pure EPA Active Pharmaceutical Ingredient (API) product scope, market overview, market estimation caveats and base year.
    Chapter 2, to profile the top manufacturers of Pure EPA Active Pharmaceutical Ingredient (API), with price, sales quantity, revenue, and global market share of Pure EPA Active Pharmaceutical Ingredient (API) from 2021 to 2026.
    Chapter 3, the Pure EPA Active Pharmaceutical Ingredient (API) competitive situation, sales quantity, revenue, and global market share of top manufacturers are analyzed emphatically by landscape contrast.
    Chapter 4, the Pure EPA Active Pharmaceutical Ingredient (API) breakdown data are shown at the regional level, to show the sales quantity, consumption value, and growth by regions, from 2021 to 2032.
    Chapter 5 and 6, to segment the sales by Type and by Application, with sales market share and growth rate by Type, by Application, from 2021 to 2032.
    Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales quantity, consumption value, and market share for key countries in the world, from 2021 to 2026.and Pure EPA Active Pharmaceutical Ingredient (API) market forecast, by regions, by Type, and by Application, with sales and revenue, from 2027 to 2032.
    Chapter 12, market dynamics, drivers, restraints, trends, and Porters Five Forces analysis.
    Chapter 13, the key raw materials and key suppliers, and industry chain of Pure EPA Active Pharmaceutical Ingredient (API).
    Chapter 14 and 15, to describe Pure EPA Active Pharmaceutical Ingredient (API) sales channel, distributors, customers, research findings and conclusion.

    Buy now